Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

S-1/A

SEC Filing Details

Document Details

Form
Filing Date
Jul 19, 2012
Document Date
Jul 19, 2012
Form Description
Amended Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved